Literature DB >> 22350586

Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden.

Henrik Olsen1, Erik Nordenström, Anders Bergenfelz, Ulf Nyman, Stig Valdemarsson, Erik Palmqvist.   

Abstract

Evaluation of subclinical hypercortisolism (SH) in patients with adrenal incidentaloma (AI) including its correlation to size, attenuation at unenhanced computed tomography (CT) and unilateral or bilateral adrenal disease. Nine hospitals in Southern Sweden investigated during 2005-2007 consecutively patients with AI with hormonal and CT examinations according a regional protocol. Two hundred and twenty-eight patients with AI with median size 2.0 cm were included. One mg overnight dexamethasone suppression test (DST) was performed in 223 patients and basal P-ACTH measured in 146 patients. SH was defined as cortisol ≥ 50 nmol/l at DST in combination with basal ACTH <2 pmol/l. In patients with unilateral AI 42% (76/180) had inadequate suppression at DST and 23% (27/115) had SH. The probability for SH and inadequate suppression at DST correlated positively to size and inversely to attenuation at CT. Bilateral AI were found in 43 patients and of these 70% (30/43) had inadequate suppression at DST and 42% (13/31) SH. The patients with SH or inadequate suppression at DST had increased frequency of hypertension which increased further in patients with post-DST cortisol ≥ 140 nmol/l. The applied criterion for SH is useful for initial evaluation of patients with AI. SH is common in patients with AI, particular in bilateral disease. In patients with unilateral AI the probability for SH correlated positively to size and inversely to attenuation at CT. Furthermore, SH and the post-DST cortisol concentration was associated with hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350586     DOI: 10.1007/s12020-012-9622-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  33 in total

1.  Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas.

Authors:  L Barzon; F Fallo; N Sonino; M Boscaro
Journal:  Eur J Endocrinol       Date:  2001-08       Impact factor: 6.664

2.  Overrepresentation of the N363S variant of the glucocorticoid receptor gene in patients with bilateral adrenal incidentalomas.

Authors:  Judit Majnik; Attila Patocs; Katalin Balogh; Miklos Toth; Peter Gergics; Agnes Szappanos; Agnes Mondok; Gabor Borgulya; Pal Panczel; Zoltan Prohaszka; Karoly Racz
Journal:  J Clin Endocrinol Metab       Date:  2006-04-24       Impact factor: 5.958

Review 3.  Adrenal imaging.

Authors:  Michael A Blake; Carmel G Cronin; Giles W Boland
Journal:  AJR Am J Roentgenol       Date:  2010-06       Impact factor: 3.959

4.  Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.

Authors:  Abdurrahman Comlekci; Serkan Yener; Senem Ertilav; Mustafa Secil; Baris Akinci; Tevfik Demir; Levent Kebapcilar; Firat Bayraktar; Sena Yesil; Sevinc Eraslan
Journal:  Endocrine       Date:  2009-10-30       Impact factor: 3.633

5.  Low investigation rate for adrenal incidentalomas.

Authors:  S Bujawansa; D Bowen-Jones
Journal:  Endocrine       Date:  2011-05-12       Impact factor: 3.633

6.  Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.

Authors:  L Barzon; C Scaroni; N Sonino; F Fallo; M Gregianin; C Macrì; M Boscaro
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

7.  Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.

Authors:  Dieter H Szolar; Melvyn Korobkin; Pia Reittner; Andrea Berghold; Thomas Bauernhofer; Harald Trummer; Helmut Schoellnast; Klaus W Preidler; Hellmuth Samonigg
Journal:  Radiology       Date:  2005-02       Impact factor: 11.105

8.  Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery.

Authors:  Giampaolo Bernini; Angelica Moretti; Pietro Iacconi; Paolo Miccoli; Renato Nami; Barbara Lucani; Antonio Salvetti
Journal:  Eur J Endocrinol       Date:  2003-02       Impact factor: 6.664

9.  Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome.

Authors:  G G Garrapa; P Pantanetti; G Arnaldi; F Mantero; E Faloia
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

10.  The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome.

Authors:  S Tsagarakis; P Kokkoris; C Roboti; C Malagari; J Kaskarelis; V Vlassopoulou; C Alevizaki; N Thalassinos
Journal:  Clin Endocrinol (Oxf)       Date:  1998-05       Impact factor: 3.478

View more
  15 in total

1.  Subclinical hypercortisolism: debatable or visible on the lightbox?

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

2.  DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous?

Authors:  Serkan Yener; Hamiyet Yilmaz; Tevfik Demir; Mustafa Secil; Abdurrahman Comlekci
Journal:  Endocrine       Date:  2014-08-22       Impact factor: 3.633

Review 3.  Screening for Cushing's syndrome: is it worthwhile?

Authors:  Ilan Shimon
Journal:  Pituitary       Date:  2015-04       Impact factor: 4.107

4.  Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.

Authors:  Marta Araujo-Castro; César Mínguez Ojeda; María Noelia Sánchez Ramírez; Victoria Gómez Dos Santos; Eider Pascual-Corrrales; María Fernández-Argüeso
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

Review 5.  Subclinical Cushing's syndrome in patients with bilateral compared to unilateral adrenal incidentalomas: a systematic review and meta-analysis.

Authors:  Stavroula A Paschou; Eleni Kandaraki; Fotini Dimitropoulou; Dimitrios G Goulis; Andromachi Vryonidou
Journal:  Endocrine       Date:  2015-10-24       Impact factor: 3.633

6.  Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center.

Authors:  Jekaterina Patrova; Magnus Kjellman; Hans Wahrenberg; Henrik Falhammar
Journal:  Endocrine       Date:  2017-09-08       Impact factor: 3.633

7.  Can abdominal CT features predict autonomous cortisol secretion in patients with adrenal nodules?

Authors:  Michael T Corwin; Christopher Lan; Machelle Wilson; Thomas W Loehfelm; Michael J Campbell
Journal:  Abdom Radiol (NY)       Date:  2021-05-07

Review 8.  Adrenal Incidentaloma.

Authors:  Mark Sherlock; Andrew Scarsbrook; Afroze Abbas; Sheila Fraser; Padiporn Limumpornpetch; Rosemary Dineen; Paul M Stewart
Journal:  Endocr Rev       Date:  2020-12-01       Impact factor: 19.871

9.  Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas.

Authors:  M Araujo-Castro; C Robles Lázaro; P Parra Ramírez; R García Centeno; P Gracia Gimeno; M T Fernández-Ladreda; M A Sampedro Núñez; M Marazuela; H F Escobar-Morreale; P Valderrabano
Journal:  J Endocrinol Invest       Date:  2021-03-08       Impact factor: 4.256

Review 10.  Approach to the Patient With Adrenal Incidentaloma.

Authors:  Irina Bancos; Alessandro Prete
Journal:  J Clin Endocrinol Metab       Date:  2021-10-21       Impact factor: 6.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.